金燕露,于爱军,段 萍,等.卵巢透明细胞癌的诊断及治疗研究进展[J].肿瘤学杂志,2023,29(7):544-553. |
卵巢透明细胞癌的诊断及治疗研究进展 |
Progress on the Diagnosis and Treatment of Ovarian Clear Cell Carcinoma |
投稿时间:2023-02-09 |
DOI:10.11735/j.issn.1671-170X.2023.07.B002 |
|
|
中文关键词: 卵巢透明细胞癌 诊断与治疗 致病基因 手术 分子靶向治疗 |
英文关键词:ovarian clear cell carcinoma diagnosis and treatment pathogenic gene surgery molecular targeted therapy |
基金项目:国家自然科学基金面上项目(82274266) |
|
摘要点击次数: 548 |
全文下载次数: 185 |
中文摘要: |
摘 要:卵巢透明细胞癌是上皮性卵巢癌中恶性程度最高,预后最差的一个亚型。目前对于卵巢透明细胞癌的治疗以手术治疗为主。 近年来,根据卵巢透明细胞癌独特的致病基因提出了许多可能的分子靶向治疗。全文就卵巢透明细胞癌的临床特点、辅助检查、发病机制、致病基因、手术治疗和分子靶向治疗作一综述。 |
英文摘要: |
Abstract:Ovarian clear cell carcinoma(OCCC) is a subtype of epithelial ovarian carcinoma with high malignancy and the poor prognosis. Surgery has been the main treatment for ovarian clear cell carcinoma. However, at present molecular targeted therapies for OCCC are proposed according its unique pathogenic genes. This paper reviews the clinical features, auxiliary examinations, pathogenesis, pathogenic genes, surgical treatment and molecular targeted therapy of ovarian clear cell carcinoma. |
在线阅读
查看全文 查看/发表评论 下载PDF阅读器 |